169 related articles for article (PubMed ID: 18765292)
1. S100A6 binds p53 and affects its activity.
Słomnicki ŁP; Nawrot B; Leśniak W
Int J Biochem Cell Biol; 2009 Apr; 41(4):784-90. PubMed ID: 18765292
[TBL] [Abstract][Full Text] [Related]
2. P53-dependent suppression of the human calcyclin gene (S100A6): the role of Sp1 and of NFkappaB.
Króliczak W; Pietrzak M; Puzianowska-Kuznicka M
Acta Biochim Pol; 2008; 55(3):559-70. PubMed ID: 18714402
[TBL] [Abstract][Full Text] [Related]
3. Binding and functional characteristics of two E-box motifs within the S100A6 (calcyclin) gene promoter.
Leśniak W; Kuźnicki J
J Cell Biochem; 2006 Apr; 97(5):1017-24. PubMed ID: 16288473
[TBL] [Abstract][Full Text] [Related]
4. S100A6 (calcyclin) enhances the sensitivity to apoptosis via the upregulation of caspase-3 activity in Hep3B cells.
Joo JH; Yoon SY; Kim JH; Paik SG; Min SR; Lim JS; Choe IS; Choi I; Kim JW
J Cell Biochem; 2008 Mar; 103(4):1183-97. PubMed ID: 17721932
[TBL] [Abstract][Full Text] [Related]
5. S100A6 mediates nuclear translocation of Sgt1: a heat shock-regulated protein.
Prus W; Filipek A
Amino Acids; 2011 Oct; 41(4):781-7. PubMed ID: 20213445
[TBL] [Abstract][Full Text] [Related]
6. Proteomic profiling in distinct cellular compartments of tumor cells reveals p53-dependent upregulation of S100A6 upon induction of telomere dysfunction.
Zimmermann S; Biniossek ML; Maurer C; Münzer P; Pantic M; Veelken H; Martens UM
Proteomics; 2009 Nov; 9(22):5175-87. PubMed ID: 19834903
[TBL] [Abstract][Full Text] [Related]
7. High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients.
Vimalachandran D; Greenhalf W; Thompson C; Lüttges J; Prime W; Campbell F; Dodson A; Watson R; Crnogorac-Jurcevic T; Lemoine N; Neoptolemos J; Costello E
Cancer Res; 2005 Apr; 65(8):3218-25. PubMed ID: 15833853
[TBL] [Abstract][Full Text] [Related]
8. S100A6 competes with the TAZ2 domain of p300 for binding to p53 and attenuates p53 acetylation.
Graczyk A; Słomnicki LP; Leśniak W
J Mol Biol; 2013 Sep; 425(18):3488-94. PubMed ID: 23796514
[TBL] [Abstract][Full Text] [Related]
9. Posttranslational modifications affect the interaction of S100 proteins with tumor suppressor p53.
van Dieck J; Teufel DP; Jaulent AM; Fernandez-Fernandez MR; Rutherford TJ; Wyslouch-Cieszynska A; Fersht AR
J Mol Biol; 2009 Dec; 394(5):922-30. PubMed ID: 19819244
[TBL] [Abstract][Full Text] [Related]
10. Hsp70 is a new target of Sgt1--an interaction modulated by S100A6.
Spiechowicz M; Zylicz A; Bieganowski P; Kuznicki J; Filipek A
Biochem Biophys Res Commun; 2007 Jun; 357(4):1148-53. PubMed ID: 17466273
[TBL] [Abstract][Full Text] [Related]
11. S100A6 (calcyclin) deficiency induces senescence-like changes in cell cycle, morphology and functional characteristics of mouse NIH 3T3 fibroblasts.
Słomnicki LP; Leśniak W
J Cell Biochem; 2010 Feb; 109(3):576-84. PubMed ID: 20013795
[TBL] [Abstract][Full Text] [Related]
12. HMGA1 inhibits the function of p53 family members in thyroid cancer cells.
Frasca F; Rustighi A; Malaguarnera R; Altamura S; Vigneri P; Del Sal G; Giancotti V; Pezzino V; Vigneri R; Manfioletti G
Cancer Res; 2006 Mar; 66(6):2980-9. PubMed ID: 16540646
[TBL] [Abstract][Full Text] [Related]
13. S100A6 - new facts and features.
Leśniak W; Słomnicki ŁP; Filipek A
Biochem Biophys Res Commun; 2009 Dec; 390(4):1087-92. PubMed ID: 19891957
[TBL] [Abstract][Full Text] [Related]
14. The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target.
Ohuchida K; Mizumoto K; Ishikawa N; Fujii K; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
Clin Cancer Res; 2005 Nov; 11(21):7785-93. PubMed ID: 16278400
[TBL] [Abstract][Full Text] [Related]
15. CacyBP/SIP binds ERK1/2 and affects transcriptional activity of Elk-1.
Kilanczyk E; Filipek S; Jastrzebska B; Filipek A
Biochem Biophys Res Commun; 2009 Feb; 380(1):54-9. PubMed ID: 19166809
[TBL] [Abstract][Full Text] [Related]
16. Restoring wild-type conformation and DNA-binding activity of mutant p53 is insufficient for restoration of transcriptional activity.
Brazda V; Muller P; Brozkova K; Vojtesek B
Biochem Biophys Res Commun; 2006 Dec; 351(2):499-506. PubMed ID: 17070499
[TBL] [Abstract][Full Text] [Related]
17. S100A6 is a negative regulator of the induction of cardiac genes by trophic stimuli in cultured rat myocytes.
Tsoporis JN; Marks A; Haddad A; O'Hanlon D; Jolly S; Parker TG
Exp Cell Res; 2005 Feb; 303(2):471-81. PubMed ID: 15652358
[TBL] [Abstract][Full Text] [Related]
18. S100A6 is transcriptionally regulated by β-catenin and interacts with a novel target, lamin A/C, in colorectal cancer cells.
Kilańczyk E; Graczyk A; Ostrowska H; Kasacka I; Leśniak W; Filipek A
Cell Calcium; 2012 Jun; 51(6):470-7. PubMed ID: 22560296
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation by p53: one protein, many possibilities.
Laptenko O; Prives C
Cell Death Differ; 2006 Jun; 13(6):951-61. PubMed ID: 16575405
[TBL] [Abstract][Full Text] [Related]
20. Influence of magnesium ion on the binding of p53 DNA-binding domain to DNA-response elements.
Xue Y; Wang S; Feng X
J Biochem; 2009 Jul; 146(1):77-85. PubMed ID: 19297420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
